Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₩ 10050
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Favourable price performance
Data is available to registered users only
Data is available to registered users only
About
JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers botulinum toxins, fillers, anti-aging solutions, lifting threads for medical treatment, laser surgical instruments, and skin care hyaluronic acid masks. The company is headquartered in Wonju, South Korea.
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is of fair value on EV/EBITDA, overvalued on P/FC.
Data is available to registered users only
Buy
Sell